High-Dose Versus Standard-Dose Intensity-Modulated Radiotherapy With Concurrent Paclitaxel Plus Carboplatin for Patients With Thoracic Esophageal Squamous Cell Carcinoma: A Randomized, Multicenter, Open-Label, Phase 3 Superiority Trial
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation
Reference28 articles.
1. Global incidence of oesophageal cancer by histological subtype in 2012;Arnold;Gut,2015
2. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus;Herskovic;New Engl J Med,1992
3. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: High-dose versus standard-dose radiation therapy;Minsky;J Clin Oncol,2002
4. Preoperative chemoradiotherapy for esophageal or junctional cancer;van Hagen;New Engl J Med,2012
5. Volumetric modulation arc radiotherapy with flattening filter-free beams compared with static gantry IMRT and 3D conformal radiotherapy for advanced esophageal cancer: A feasibility study;Nicolini;Int J Radiat Oncol Biol Phys,2012
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Concurrent chemoradiotherapyof different radiation doses and different irradiation fields for locally advanced thoracic esophageal squamous cell carcinoma: A randomized, multicenter, phase III clinical trial;Cancer Communications;2024-08-19
2. Dose Escalation in Radical Radio(chemo)therapy for Cervical and Upper Thoracic Esophageal Cancer with 3DCRT/IMRT (ChC&UES): A Multi-center Real world Study;2024-06-04
3. Effectiveness and safety of combined nimotuzumab and S-1 chemotherapy with concurrent radiotherapy for locally advanced esophageal cancer in malnourished and elderly patients: A prospective phase II study;CHINESE J CANCER RES;2024
4. Esophagogastric Cancer;Hematology/Oncology Clinics of North America;2024-06
5. Multi-disciplinary management of esophageal carcinoma: Current practices and future directions;Critical Reviews in Oncology/Hematology;2024-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3